Community-based door to door census of suspected people living with epilepsy: empowering community drug distributors to improve the provision of care to rural communities in Cameroon.
Community drug distributors
Distribution
Epilepsy
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
05 Jun 2020
05 Jun 2020
Historique:
received:
12
09
2019
accepted:
27
05
2020
entrez:
7
6
2020
pubmed:
7
6
2020
medline:
11
11
2020
Statut:
epublish
Résumé
Epilepsy is a severe neurological disorder with huge psychological, social, and economic consequences, including premature deaths and loss of productivity. Sub-Saharan Africa carries the highest burden of epilepsy. The management of epilepsy in Cameroon remains unsatisfactory due to poor identification of cases and a limited knowledge of the distribution of the disease. The objective of this study was to determine whether community drug distributors (CDDs) - volunteers selected by their communities to distribute ivermectin against onchocerciasis and who have been proven efficient to deliver other health interventions such as insecticide-treated bed nets to prevent malaria, vitamin A tablets, and albendazole to treat soil transmitted helminthiasis - can be used to reliably identify people living with epilepsy to promote better management of cases. This study was carried out in three health Districts in Cameroon. An exhaustive house to house census was carried out by trained CDDs under the supervision of local nurses. In each household, all suspected cases of epilepsy were identified. In each health district, five communities were randomly selected for a second census by trained health personnel (research team). The results of the two censuses were compared for verification purposes. A total of 53,005 people was registered in the 190 communities surveyed with 794 (1.4%) individuals identified as suspected cases of epilepsy (SCE) by the CDDs. In the 15 communities where the SCE census was verified, the average ratio between the number of suspected cases of epilepsy reported in a community by the research team and that reported by the CDDs was 1.1; this ratio was < 0.8 and > 1.2 in 6 communities. The results of this study suggest that CDDs, who are present in about 200,000 communities in 31 Sub Saharan African countries where onchocerciasis is endemic, can be successfully used to assess epilepsy prevalence, and therefore map epilepsy in many African countries.
Sections du résumé
BACKGROUND
BACKGROUND
Epilepsy is a severe neurological disorder with huge psychological, social, and economic consequences, including premature deaths and loss of productivity. Sub-Saharan Africa carries the highest burden of epilepsy. The management of epilepsy in Cameroon remains unsatisfactory due to poor identification of cases and a limited knowledge of the distribution of the disease. The objective of this study was to determine whether community drug distributors (CDDs) - volunteers selected by their communities to distribute ivermectin against onchocerciasis and who have been proven efficient to deliver other health interventions such as insecticide-treated bed nets to prevent malaria, vitamin A tablets, and albendazole to treat soil transmitted helminthiasis - can be used to reliably identify people living with epilepsy to promote better management of cases.
METHODS
METHODS
This study was carried out in three health Districts in Cameroon. An exhaustive house to house census was carried out by trained CDDs under the supervision of local nurses. In each household, all suspected cases of epilepsy were identified. In each health district, five communities were randomly selected for a second census by trained health personnel (research team). The results of the two censuses were compared for verification purposes.
RESULTS
RESULTS
A total of 53,005 people was registered in the 190 communities surveyed with 794 (1.4%) individuals identified as suspected cases of epilepsy (SCE) by the CDDs. In the 15 communities where the SCE census was verified, the average ratio between the number of suspected cases of epilepsy reported in a community by the research team and that reported by the CDDs was 1.1; this ratio was < 0.8 and > 1.2 in 6 communities.
CONCLUSIONS
CONCLUSIONS
The results of this study suggest that CDDs, who are present in about 200,000 communities in 31 Sub Saharan African countries where onchocerciasis is endemic, can be successfully used to assess epilepsy prevalence, and therefore map epilepsy in many African countries.
Identifiants
pubmed: 32503495
doi: 10.1186/s12889-020-08997-8
pii: 10.1186/s12889-020-08997-8
pmc: PMC7275343
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
871Références
Int Q Community Health Educ. 2015;35(4):295-316
pubmed: 26470395
Hum Resour Health. 2012 Sep 27;10:37
pubmed: 23017106
PLoS Negl Trop Dis. 2009 Jun 16;3(6):e461
pubmed: 19529767
Epilepsia. 2010 May;51(5):830-7
pubmed: 19919664
Epilepsy Behav. 2010 Jan;17(1):95-102
pubmed: 19932640
Bull Soc Pathol Exot. 2000 Nov;93(4):276-8
pubmed: 11204728
Lancet Neurol. 2014 Oct;13(10):1029-44
pubmed: 25231525
Tanzan J Health Res. 2009 Jul;11(3):116-25
pubmed: 20734708
Tanzan J Health Res. 2008 Oct;10(4):232-9
pubmed: 19402585
Epilepsy Behav. 2009 Jan;14(1):83-8
pubmed: 18845276
Parasit Vectors. 2016 Nov 14;9(1):581
pubmed: 27842567
Trop Med Int Health. 2013 Feb;18(2):188-93
pubmed: 23279554
Infect Dis Poverty. 2016 Jun 27;5(1):66
pubmed: 27349645
Am J Trop Med Hyg. 2002 Sep;67(3):266-72
pubmed: 12408665
Epilepsia. 2010 May;51(5):883-90
pubmed: 20067507
Glob Public Health. 2008;3(2):187-96
pubmed: 19288370
Am J Trop Med Hyg. 2015 Jan;92(1):115-7
pubmed: 25331802
Epilepsia. 2011 Aug;52(8):1376-81
pubmed: 21627649
Epilepsia. 2003 Jul;44(7):956-63
pubmed: 12823580
Community Eye Health. 2005 Jun;18(54):92-3
pubmed: 17491758
Br J Ophthalmol. 2007 Aug;91(8):995-9
pubmed: 17431019
Infect Dis Poverty. 2019 Feb 10;8(1):11
pubmed: 30738437
PLoS Negl Trop Dis. 2015 Dec 11;9(12):e0004270
pubmed: 26658938
Epilepsia. 2008 Sep;49(9):1491-503
pubmed: 18557778
Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24;368(1623):20120146
pubmed: 23798694
Epilepsy Res. 2008 Dec;82(2-3):200-10
pubmed: 18976884
Bull Soc Pathol Exot. 2004 May;97(2):105-8
pubmed: 15255351
Trans R Soc Trop Med Hyg. 2002 Sep-Oct;96(5):537-41
pubmed: 12474484
Epilepsia. 2005;46 Suppl 11:33-5
pubmed: 16393176
Ann Trop Med Parasitol. 1997 Jun;91(4):379-91
pubmed: 9290845
Pan Afr Med J. 2013;14:32
pubmed: 23503525
Infect Dis Poverty. 2019 Jan 23;8(1):8
pubmed: 30670093
Rev Infect Dis. 1984 May-Jun;6 Suppl 2:S376-8
pubmed: 6740076
PLoS Negl Trop Dis. 2013;7(3):e2147
pubmed: 23556028
Lancet Neurol. 2005 Jan;4(1):21-31
pubmed: 15620854
J Glob Health. 2012 Dec;2(2):020405
pubmed: 23289080
Int J Epidemiol. 2000 Apr;29(2):330-5
pubmed: 10817133
Epilepsy Behav. 2009 Oct;16(2):254-9
pubmed: 19751991
Epilepsia. 1991 Jul-Aug;32(4):429-45
pubmed: 1868801
Neuroepidemiology. 1988;7(3):115-21
pubmed: 3136404
Child Care Health Dev. 2007 May;33(3):249-56
pubmed: 17439437
PLoS One. 2015 Feb 06;10(2):e0116820
pubmed: 25658103
Pan Afr Med J. 2014 Dec 18;19:389
pubmed: 25995785
PLoS Negl Trop Dis. 2012;6(8):e1775
pubmed: 22905274
Epilepsia. 2005 Apr;46(4):470-2
pubmed: 15816939
Emerg Themes Epidemiol. 2012 Nov 21;9(1):8
pubmed: 23171721
Acta Neurol Scand. 2014 Feb;129(2):109-13
pubmed: 24127647
Indian J Pediatr. 1991 Mar-Apr;58(2):239-43
pubmed: 1879905
Parasit Vectors. 2014 Jul 22;7:326
pubmed: 25053392
Bull World Health Organ. 2010 Jul 1;88(7):509-18
pubmed: 20616970
Neurology. 2011 Sep 6;77(10):1005-12
pubmed: 21893672
Ann Trop Med Parasitol. 2002 Mar;96 Suppl 1:S93-104
pubmed: 12081254
Lancet. 2012 Sep 29;380(9848):1193-201
pubmed: 23021288
Int J Epidemiol. 1998 Aug;27(4):672-6
pubmed: 9758124
Lancet Neurol. 2008 Jan;7(1):50-6
pubmed: 18068520
Disabil Rehabil. 2010;32(1):79-85
pubmed: 19925280
Trends Parasitol. 2012 Jun;28(6):231-8
pubmed: 22503153
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Parasit Vectors. 2019 Mar 19;12(1):114
pubmed: 30890155
Lancet Neurol. 2009 Jan;8(1):32-3
pubmed: 19081513
Bull World Health Organ. 2010 Apr;88(4):260-6
pubmed: 20431789
Trans R Soc Trop Med Hyg. 2015 Apr;109(4):233-8
pubmed: 25631856